News Coverage 04.23.21 Share on Twitter Share on Facebook Share on LinkedIn Tumor-infiltrating lymphocytes show ‘provocative’ response rates in advanced melanoma Related Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment